Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolkin

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Psychiatry Research|October 1, 1986
Factors affecting TRH test resultsA Wolkin
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1977
Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in ratsP Consroe, A Wolkin
Schizophrenia Research|October 1, 1991
Amphetamine response and duration of illness in schizophreniaB Angrist, M Sanfilipo, A Wolkin
Clinical Neuropharmacology|June 8, 2001
Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidolB Angrist, M Sanfilipo, A Wolkin
Biological Psychiatry|November 1, 1986
Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenicsP Fiedler, A Wolkin, J Rotrosen
Psychopharmacology|January 1, 1985
Amphetamine response and relapse risk after depot neuroleptic discontinuationB Angrist, E Peselow, M Rubinstein, et al.
The American Journal of Psychiatry|July 1, 1986
Essential fatty acid supplementation in tardive dyskinesiaA Wolkin, B Jordan, E Peselow, et al.
Alcoholism, Clinical and Experimental Research|February 1, 1987
Essential fatty acid supplementation during early alcohol abstinenceA Wolkin, D Segarnick, J Sierkierski, et al.
Journal of Neural Transmission. General Section|January 1, 1994
Persistent psychosis after reduction in pre- and post-synaptic dopaminergic functionA Wolkin, E Duncan, M Sanfilipo, et al.
Journal of Affective Disorders|June 1, 1984
TRH test abnormalities in psychiatric disordersA Wolkin, E D Peselow, M Smith, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Psychiatry Research|October 1, 1986
Factors affecting TRH test resultsA Wolkin
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1977
Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in ratsP Consroe, A Wolkin
Schizophrenia Research|October 1, 1991
Amphetamine response and duration of illness in schizophreniaB Angrist, M Sanfilipo, A Wolkin
Clinical Neuropharmacology|June 8, 2001
Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidolB Angrist, M Sanfilipo, A Wolkin
Biological Psychiatry|November 1, 1986
Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenicsP Fiedler, A Wolkin, J Rotrosen
Psychopharmacology|January 1, 1985
Amphetamine response and relapse risk after depot neuroleptic discontinuationB Angrist, E Peselow, M Rubinstein, et al.
The American Journal of Psychiatry|July 1, 1986
Essential fatty acid supplementation in tardive dyskinesiaA Wolkin, B Jordan, E Peselow, et al.
Alcoholism, Clinical and Experimental Research|February 1, 1987
Essential fatty acid supplementation during early alcohol abstinenceA Wolkin, D Segarnick, J Sierkierski, et al.
Journal of Neural Transmission. General Section|January 1, 1994
Persistent psychosis after reduction in pre- and post-synaptic dopaminergic functionA Wolkin, E Duncan, M Sanfilipo, et al.
Journal of Affective Disorders|June 1, 1984
TRH test abnormalities in psychiatric disordersA Wolkin, E D Peselow, M Smith, et al.
Pageof 4